These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17870203)

  • 1. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy.
    Yu HM; Liu YF; Cheng YF; Hu LK; Hou M
    Lung Cancer; 2008 Feb; 59(2):219-26. PubMed ID: 17870203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer.
    Liu Y; Yu H; Zhang C; Cheng Y; Hu L; Meng X; Zhao Y
    Eur J Cancer; 2008 Nov; 44(16):2425-32. PubMed ID: 18789680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
    Zhao L; Sheldon K; Chen M; Yin MS; Hayman JA; Kalemkerian GP; Arenberg D; Lyons SE; Curtis JL; Davis M; Cease KB; Brenner D; Anscher MS; Lawrence TS; Kong FM
    Lung Cancer; 2008 Feb; 59(2):232-9. PubMed ID: 17905467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
    Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
    Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
    Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients.
    Zheng L; Walters EH; Wang N; Whitford H; Orsida B; Levvey B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2004 Apr; 23(4):446-55. PubMed ID: 15063404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma.
    Kong F; Jirtle RL; Huang DH; Clough RW; Anscher MS
    Cancer; 1999 Nov; 86(9):1712-9. PubMed ID: 10547543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of high-dose three-dimensional conformal radiotherapy and conventional radiotherapy for non-small-cell lung cancer.
    Xu SJ; Shi YS; Song HC; Chen LH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):937-8. PubMed ID: 12377626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury.
    Anscher MS; Thrasher B; Zgonjanin L; Rabbani ZN; Corbley MJ; Fu K; Sun L; Lee WC; Ling LE; Vujaskovic Z
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):829-37. PubMed ID: 18411002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
    Vujaskovic Z; Feng QF; Rabbani ZN; Samulski TV; Anscher MS; Brizel DM
    Exp Lung Res; 2002; 28(7):577-90. PubMed ID: 12396250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy.
    Chen HW; Chang YC; Lai YL; Chen YJ; Huang MJ; Leu YS; Fu YK; Wang LW; Hwang JJ
    Jpn J Clin Oncol; 2005 Aug; 35(8):427-32. PubMed ID: 16006572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy.
    Stenmark MH; Cai XW; Shedden K; Hayman JA; Yuan S; Ritter T; Ten Haken RK; Lawrence TS; Kong FM
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e217-22. PubMed ID: 22935395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
    Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer.
    Cai XW; Shedden K; Ao X; Davis M; Fu XL; Lawrence TS; Lubman DM; Kong FM
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):867-76. PubMed ID: 20510197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profiling for prediction of symptomatic radiation-induced lung injury.
    Hart JP; Broadwater G; Rabbani Z; Moeller BJ; Clough R; Huang D; Sempowski GA; Dewhirst M; Pizzo SV; Vujaskovic Z; Anscher MS
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1448-54. PubMed ID: 16115739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-treatment plasma transforming growth factor beta 1 (TGF-beta1) level predicts for late morbidity in patients with advanced head and neck cancer.
    Feltl D; Závadová E; Pála M; Hozák P
    Neoplasma; 2005; 52(5):393-7. PubMed ID: 16151583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced cell cycle response in lymphocytes is not related to clinical side-effects in breast cancer patients.
    Tell R; Edgren MR; Sverrisdottir A; Castro J; Fornander T; Hansson LO; Skog S; Lewensohn R
    Anticancer Res; 2003; 23(3C):3077-83. PubMed ID: 12926165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.